Galectin-13 antibody
Principal name
Galectin-13 antibody
Alternative names for Galectin-13 antibody
LGALS13, PLAC8, Galactoside-binding soluble lectin 13, EC=3.1.1.5, Placental tissue protein 13, Placenta protein 13, PP13, Galectin13
Gene ID
29124 (LGALS13)
Ncbi ID
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Western blot / Immunoblot (WB)
Background of Galectin-13 antibody
- Kit Component:
- - KN209738G1, LGALS13 gRNA vector 1 in pCas-Guide vector
- KN209738G2, LGALS13 gRNA vector 2 in pCas-Guide vector
- KN209738D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Than NG, Pick E, et al. (2004). Eur J Biochem. 271(6):1065-78.
Visegrady B, Than NG, et al. (2001). Protein Eng. 14(11):875-80.
Western Blot analysis of LGALS13 expression in transfected 293T cell line (H00029124-T01) by LGALS13 MaxPab polyclonal antibody.Lane1:LGALS13 transfected lysate(15.29 KDa).Lane2:Non-transfected lysate.
Human Heart; WB Suggested Anti-LGALS13 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:312500. Positive Control: Human heart; LGALS13 antibody - N-terminal region (ARP42376_P050) in Human Heart cells using Western Blot
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP309738 | Galectin-13 |
||||
| Recombinant protein of human lectin, galactoside-binding, soluble, 13 (LGALS13) | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY415702 | LGALS13 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |